Literature DB >> 19822562

Increased umbilical cord plasma interleukin-1 beta levels was correlated with adverse outcomes of neonatal hypoxic-ischemic encephalopathy.

Jing Liu1, Zhi-Chun Feng.   

Abstract

To explore whether or not the umbilical blood levels of cytokines can be used to indicate the adverse outcomes of hypoxic-ischemic encephalopathy (HIE) patients. Umbilical artery blood and peripheral venous blood samples were collected on the 1st, 3rd and 7th days after birth to detect the levels of IL-1 beta, IL-8 and TNF-alpha. Neurological examination and Denver developmental screening test (DDST-II) were performed at the 6 and 12 months evaluations to detect any neurodevelopmental abnormalities. The results showed: (i) the serum concentrations of IL-1 beta, IL-8 and TNF-alpha in umbilical and peripheral blood were significantly higher in HIE patients than control groups; (ii) the umbilical blood concentrations of IL-1 beta exhibited the best positive correlation with HIE grades, when compared with IL-8 and TNF-alpha; and (iii) abnormal neurological outcomes at 6 and 12 months of age were best predicted by umbilical levels of IL-1 beta. Thus, umbilical concentrations of IL-1 beta were associated with the grades and adverse outcomes of HIE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822562     DOI: 10.1093/tropej/fmp098

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  17 in total

1.  Systemic infusions of anti-interleukin-1β neutralizing antibodies reduce short-term brain injury after cerebral ischemia in the ovine fetus.

Authors:  Xiaodi Chen; Virginia Hovanesian; Syed Naqvi; Yow-Pin Lim; Richard Tucker; John E Donahue; Edward G Stopa; Barbara S Stonestreet
Journal:  Brain Behav Immun       Date:  2017-08-02       Impact factor: 7.217

2.  A question of cytokine signaling in the fetus.

Authors:  Charles E Wood
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-17       Impact factor: 6.200

3.  Inflammatory mediators as predictors of outcome in perinatal asphyxia.

Authors:  B Bharathi; B Vishnu Bhat; V S Negi; B Adhisivam
Journal:  Indian J Pediatr       Date:  2014-10-04       Impact factor: 1.967

4.  A Role for the Inflammasome in Spontaneous Preterm Labor With Acute Histologic Chorioamnionitis.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Yi Xu; Olesya Plazyo; Ronald Unkel; Yaozhu Leng; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Bogdan Panaitescu; Zhong Dong; Adi L Tarca; Vikki M Abrahams; Lami Yeo; Sonia S Hassan
Journal:  Reprod Sci       Date:  2017-01-26       Impact factor: 3.060

Review 5.  Brain-immune interactions in perinatal hypoxic-ischemic brain injury.

Authors:  Bo Li; Katherine Concepcion; Xianmei Meng; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2017-10-27       Impact factor: 11.685

Review 6.  Corticosteroids and perinatal hypoxic-ischemic brain injury.

Authors:  Katherine R Concepcion; Lubo Zhang
Journal:  Drug Discov Today       Date:  2018-05-17       Impact factor: 7.851

7.  A Role for the Inflammasome in Spontaneous Labor at Term with Acute Histologic Chorioamnionitis.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Yi Xu; Olesya Plazyo; Ronald Unkel; Nandor Gabor Than; Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Zhong Dong; Adi L Tarca; Vikki M Abrahams; Lami Yeo; Sonia S Hassan
Journal:  Reprod Sci       Date:  2016-11-16       Impact factor: 3.060

Review 8.  Oxidative Stress in Hypoxic-Ischemic Encephalopathy: Molecular Mechanisms and Therapeutic Strategies.

Authors:  Mingyi Zhao; Ping Zhu; Masayuki Fujino; Jian Zhuang; Huiming Guo; IdrisAhmed Sheikh; Lingling Zhao; Xiao-Kang Li
Journal:  Int J Mol Sci       Date:  2016-12-10       Impact factor: 5.923

Review 9.  Inflammatory responses in hypoxic ischemic encephalopathy.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Acta Pharmacol Sin       Date:  2013-07-29       Impact factor: 6.150

Review 10.  Blood Biomarkers for Evaluation of Perinatal Encephalopathy.

Authors:  Ernest M Graham; Irina Burd; Allen D Everett; Frances J Northington
Journal:  Front Pharmacol       Date:  2016-07-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.